Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems

Molecules. 2021 May 5;26(9):2703. doi: 10.3390/molecules26092703.

Abstract

Recent findings suggest that tumor microenvironment (TME) plays an important regulatory role in the occurrence, proliferation, and metastasis of tumors. Different from normal tissue, the condition around tumor significantly altered, including immune infiltration, compact extracellular matrix, new vasculatures, abundant enzyme, acidic pH value, and hypoxia. Increasingly, researchers focused on targeting TME to prevent tumor development and metastasis. With the development of nanotechnology and the deep research on the tumor environment, stimulation-responsive intelligent nanostructures designed based on TME have attracted much attention in the anti-tumor drug delivery system. TME-targeted nano therapeutics can regulate the distribution of drugs in the body, specifically increase the concentration of drugs in the tumor site, so as to enhance the efficacy and reduce adverse reactions, can utilize particular conditions of TME to improve the effect of tumor therapy. This paper summarizes the major components and characteristics of TME, discusses the principles and strategies of relevant nano-architectures targeting TME for the treatment and diagnosis systematically.

Keywords: nano therapeutics; nanoparticles; targeted therapy; tumor imaging; tumor microenvironment.

Publication types

  • Review

MeSH terms

  • Animals
  • Drug Delivery Systems*
  • Extracellular Matrix / metabolism
  • Humans
  • Hydrogen-Ion Concentration
  • Nanoparticles / chemistry*
  • Nanotechnology
  • Tumor Microenvironment*